Advances in Therapy logo Springer logo

Publisher: Springer

Related content
Volume 26, Number 7, July 2009

all issues

Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension
pp. 700-710(11)
Authors: Riccioni, Graziano; Vitulano, Nicola; D’Orazio, Nicolantonio; Bellocci, Fulvio

Dyslipidemia therapy update: the importance of full lipid profile assessment
pp. 711-718(8)
Authors: Menown, I.; Murtagh, G.; Maher, V.; Cooney, M.; Graham, I.; Tomkin, G.

Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial
pp. 719-727(9)
Authors: Busch, Regina; Graubaum, Hans-Joachim; Gruenwald, Joerg; Faergemann, Jan

Comparing hydrocortisone and methylprednisolone in patients with septic shock
pp. 728-735(8)
Authors: Yu, Teng-Jen; Liu, Yu-Chih; Yu, Chung-Chieh; Tseng, Jo-Chi; Hua, Chung-Ching; Wu, Huang-Pin

Free Content Saxagliptin: a New DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
pp. 736-736(1)
Authors: Tahrani, Abd; Piya, Milan; Barnett, Anthony

Free Content Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis
pp. 737-737(1)
Authors: Simpson, Kit; Welch, Mary; Kozel, F.; Demitrack, Mark; Nahas, Ziad

all issues

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page